Candidiasis, Invasive Completed Phase 2 Trials for MK-3118 (DB12471)

Also known as: Invasive Candidiasis / Systemic moniliasis / Systemic candida / Disseminated candidiasis / Disseminated candida / Systemic candidiasis

IndicationStatusPhase
DBCOND0036184 (Candidiasis, Invasive)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02244606Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive CandidiasisTreatment